NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Dec. 21, 2017--
Lantheus
Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus
Medical Imaging, Inc. (“LMI”), a global leader in the development,
manufacture and commercialization of innovative diagnostic imaging
agents and products, today announced that Mary Anne Heino, President and
Chief Executive Officer, and Jack Crowley, Chief Financial Officer, will
present at the 36th Annual J.P. Morgan Healthcare Conference
at 11:30 a.m. PT on Thursday, January 11, 2018 in San Francisco, CA.
To access a live webcast of the presentation and following breakout
session, please visit the Investors
section of the Company’s website at www.lantheus.com.
A replay of the webcast will be available on the Company’s website for
30 days following the live presentation.
About Lantheus Holdings, Inc. and Lantheus Medical Imaging, Inc.
Lantheus Holdings, Inc. is the parent company of LMI, a global leader in
the development, manufacture and commercialization of innovative
diagnostic imaging agents and products. LMI provides a broad portfolio
of products, including the echocardiography contrast agent DEFINITY®
Vial for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite®
(Technetium Tc99m Generator), a technetium-based generator that provides
the essential medical isotope used in nuclear medicine procedures; and
Xenon (Xenon Xe 133 Gas), an inhaled radiopharmaceutical imaging agent
used to evaluate pulmonary function and for imaging the lungs. The
Company is headquartered in North Billerica, Massachusetts with offices
in Puerto Rico and Canada. For more information, visit www.lantheus.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171221005501/en/
Source: Lantheus Holdings, Inc.
Lantheus Holdings, Inc.
Meara Murphy, 978-671-8508
Director,
Investor Relations & Corporate Communications
or
Gary
Santo, 978-671-8960
Head of Capital Markets & Investor Relations
